gyki 14166 has been researched along with hirudin in 2 studies
| Studies (gyki 14166) | Trials (gyki 14166) | Recent Studies (post-2010) (gyki 14166) | Studies (hirudin) | Trials (hirudin) | Recent Studies (post-2010) (hirudin) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 3,658 | 378 | 995 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abecassis, J; Beretz, A; Cazenave, JP; Eber, M; Fricker, JP; Klein-Soyer, C; Millon-Collard, R; Muller, D; Nicora, F | 1 |
| Callas, DD; Fareed, J | 1 |
2 other study(ies) available for gyki 14166 and hirudin
| Article | Year |
|---|---|
Adhesion of human breast cancer cell line MCF-7 to human vascular endothelial cells in culture. Enhancement by activated platelets.
Topics: Adenosine Diphosphate; Breast Neoplasms; Cell Adhesion; Cell Cycle; Cells, Cultured; Endothelium, Vascular; Epinephrine; Extracellular Matrix; Female; Fibrinogen; Heparin; Hirudins; Humans; Microscopy, Electron; Microscopy, Electron, Scanning; Oligopeptides; Platelet Aggregation; Thrombin | 1987 |
Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapy.
Topics: Antifibrinolytic Agents; Antithrombin III; Antithrombins; Aprotinin; Arginine; Binding Sites; Boron Compounds; Enzyme Activation; Fibrinolysis; Heparin; Hirudins; Humans; Oligopeptides; Peptide Fragments; Pipecolic Acids; Protein C; Recombinant Proteins; Sulfonamides; Thrombin | 1995 |